Page last updated: 2024-11-02

pd 169316 and Potassium Deficiency

pd 169316 has been researched along with Potassium Deficiency in 1 studies

2-(4-nitrophenyl)-4-(4-fluorophenyl)-5-(4-pyridinyl)-1H-imidazole: p38 MAP kinase inhibitor

Potassium Deficiency: A condition due to decreased dietary intake of potassium, as in starvation or failure to administer in intravenous solutions, or to gastrointestinal loss in diarrhea, chronic laxative abuse, vomiting, gastric suction, or bowel diversion. Severe potassium deficiency may produce muscular weakness and lead to paralysis and respiratory failure. Muscular malfunction may result in hypoventilation, paralytic ileus, hypotension, muscle twitches, tetany, and rhabomyolysis. Nephropathy from potassium deficit impairs the concentrating mechanism, producing POLYURIA and decreased maximal urinary concentrating ability with secondary POLYDIPSIA. (Merck Manual, 16th ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nath, R1
McGinnis, K1
Dutta, S1
Shivers, B1
Wang, KK1

Other Studies

1 other study available for pd 169316 and Potassium Deficiency

ArticleYear
Inhibition of p38 kinase mimics survival signal-linked protection against apoptosis in rat cerebellar granule neurons.
    Cellular & molecular biology letters, 2001, Volume: 6, Issue:2

    Topics: Animals; Apoptosis; Blotting, Western; Caspase 3; Caspase Inhibitors; Caspases; Cell Survival; Cells

2001